All News

Educational campaign launched to help nurses help patients who have treatment-related rash.

For 25 years, surgical and medical oncologists have gathered in sunny Miami to discuss the latest strategies in breast cancer management.

Experts offer advice to survivors after a study shows people with cancer have a higher risk of being unemployed than people without a history of cancer.

Men may benefit from a drug that can reduce their risk of getting prostate cancer, according to new guidelines.

Readers respond to questions posed by CURE.

A drug temporarily withdrawn from the Food and Drug Administration for approval in non-small cell lung cancer will still likely get the green light when it's resubmitted.

A new organization aims to strike back at melanoma by developing the first-ever international melanoma tissue bank.

New therapies are making headway in a difficult-to-treat cancer.

The 8th Annual Conference for Young Women Affected by Breast Cancer welcomed women diagnosed with breast cancer at 40 or younger.

Clinical trials and other relevant topics were highlighted at the 2009 Texas Forum on Blood Cancers.

Advice for survivors on looking for employment 

Young adult cancer survivors raise awareness and resources.

A brief from this year's San Antonio Breast Cancer Symposium that discusses several new studies that examine the use of hormone replacement therapies and their effects on breast cancer risk and mortality.

A brief from this year's San Antonio Breast Cancer Symposium discussing what new agents researchers have been testing when treating HER2-positive breast cancer.

A discussion about the best schedule for a class of drugs continues at the San Antonio Breast Cancer Symposium.

CURE Editor-at-Large, Kathy LaTour, tells the story of metastatic cancer survivor Brenda Hutchinson and her involvment with the HER2 Support Group

A brief from this year's San Antonio Breast Cancer Symposium where research was presented on the benefits that the drug Doxil can provide women who have relapsed after anthracycline treatment.

A brief from this year's San Antonio Breast Cancer Symposium discusses new research from eight clinical trials that studied whether or not certain factors help to predict response to neoadjuvant therapy prior to surgery.

A brief from this year's San Antonio Breast Cancer Symposium discussing new data showing that patients who receive radiation after having a mastectomy have a lesser chance of recurrence in certain early-stage cancers.

Advocate Joan Venticinque blogs about patient advocacy.

CURE publisher Susan McClure blogs from a survivor's perspective.

How a better understanding of cancer metastasis is suggesting better treatment approaches.

Why one family is committed to educating the public about male breast cancer.